bluebird bio Inc
NASDAQ:BLUE

Watchlist Manager
bluebird bio Inc Logo
bluebird bio Inc
NASDAQ:BLUE
Watchlist
Price: 4.97 USD Market Closed
Market Cap: 48.7m USD

Intrinsic Value

BLUE's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one BLUE stock under the Base Case scenario is 337.52 USD. Compared to the current market price of 4.97 USD, bluebird bio Inc is Undervalued by 99%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BLUE Intrinsic Value
337.52 USD
Undervaluation 99%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

bluebird bio Inc
NASDAQ:BLUE
US
Biotechnology
Market Cap
48.3m USD
IPO
Jun 19, 2013
US
Biotechnology
Market Cap
48.3m USD
IPO
Jun 19, 2013
Price
$false
EPS
$false
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about bluebird bio Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
bluebird bio Inc

Current Assets 154.7m
Cash & Short-Term Investments 62.3m
Receivables 3.1m
Other Current Assets 89.3m
Non-Current Assets 305.6m
PP&E 237.7m
Intangibles 15.2m
Other Non-Current Assets 52.6m
Efficiency

Free Cash Flow Analysis
bluebird bio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
bluebird bio Inc

Revenue
83.8m USD
Cost of Revenue
-89.4m USD
Gross Profit
-5.6m USD
Operating Expenses
-262.1m USD
Operating Income
-267.7m USD
Other Expenses
27m USD
Net Income
-240.7m USD
Fundamental Scores

BLUE Profitability Score
Profitability Due Diligence

bluebird bio Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
ROIC is Increasing
26/100
Profitability
Score

bluebird bio Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

BLUE Solvency Score
Solvency Due Diligence

bluebird bio Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
50/100
Solvency
Score

bluebird bio Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BLUE Price Targets Summary
bluebird bio Inc

Wall Street analysts forecast BLUE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BLUE is 7.34 USD with a low forecast of 5.05 USD and a high forecast of 10.5 USD.

Lowest
Price Target
5.05 USD
2% Upside
Average
Price Target
7.34 USD
48% Upside
Highest
Price Target
10.5 USD
111% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

bluebird bio Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for BLUE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

BLUE Insider Trading
Buy and sell transactions by insiders

BLUE News

Other Videos